About Ultromics
Ultromics is a global health technology company that specializes in leveraging artificial intelligence (AI) to enhance echocardiography analysis for the earlier and more accurate diagnosis of heart disease. Spun out of the University of Oxford in 2017, the company’s flagship EchoGo® platform utilizes advanced deep learning and machine learning algorithms to automatically interpret echocardiogram scans. This technology is designed to identify difficult-to-diagnose heart failure subtypes, such as Heart Failure with Preserved Ejection Fraction (HFpEF) and cardiac amyloidosis, which are often missed or delayed with traditional methods.
For physicians, Ultromics’ AI solutions aim to integrate seamlessly into existing echocardiography workflows, providing rapid, precise, and consistent diagnostic insights. The cloud-based platform automates key cardiac measurements, including Global Longitudinal Strain (GLS) and Ejection Fraction (EF), and generates real-time probability scores to help cardiologists identify high-risk patients. This not only improves diagnostic accuracy and reduces subjectivity but also helps alleviate the administrative burden on clinicians, allowing them to focus more on patient care and facilitate earlier, life-saving treatments. The EchoGo® platform is FDA-cleared and reimbursed by Medicare in the U.S., demonstrating its clinical validation and readiness for widespread adoption in various care settings.
Focus Areas
Business Intelligence
| Key Investors | Blue Venture Fund, Optum Ventures, Google Ventures (GV), Oxford Sciences Innovation (OSI), Legal & General (L&G), Allegis Capital, Lightrock, American Heart Association's Go Red for Women Venture Fund, UChicago Medicine's venture investment vehicle (UCM Ventures), UPMC Enterprises, Tech Nation Group, AllegisCyber, Bank of New York Mellon, Neptune, RT Ventures, GT Healthcare, Tanarra, Fushia, Andre Crawford-Brunt, Dieter Splti, Mayo Clinic Business Accelerator, Nina Capital |
| Partnerships | Mayo Clinic, Microsoft Azure Marketplace, American Society of Echocardiography (ASE), Johnson & Johnson Innovative Medicine, Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® Heart Failure (AMP®HF), Centers for Medicare and Medicaid Services (CMS), Northwestern Medicine, University of Texas Southwestern, University of Chicago, NHS, Pfizer, AstraZeneca, University Hospitals Cleveland, MedStar, Fujifilm Healthcare |
| Technology | EchoGo® platform, cloud-native, AI solutions utilizing advanced pattern recognition, deep learning, and machine learning algorithms, single view analysis of echocardiograms, integrates with existing clinical workflows and IT stacks, secure cloud VPN connection, data anonymization, SaaS (Software as a Service) |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
For physicians, Ultromics' solutions, particularly the EchoGo platform, offer a significant leap in diagnostic precision and efficiency. Expect to receive fully automated, standardized echocardiography reports with zero inter-operator variability, enabling more confident and timely clinical decisions for complex conditions like HFpEF and cardiac amyloidosis. The cloud-based nature means seamless integration into your existing workflow without IT burden, and the ability to access advanced, prognostically useful metrics like GLS without additional time or training. This translates to reduced administrative load, more time for patient care, and ultimately, improved patient outcomes through earlier and more accurate diagnoses.
Ultromics' EchoGo platform is designed for seamless, vendor-neutral integration with existing healthcare IT infrastructure. It connects to any PACS (Picture Archiving and Communication System) using standard medical formats like DICOM and can utilize HL7 messaging for improved efficiency. An API is also available for increased flexibility. The cloud-based solution ensures compatibility with all ultrasound devices and existing infrastructure, delivering results directly into clinical systems for timely decision-making.
What the Web Says
Ultromics is generally viewed as an innovative company in the healthcare AI space, particularly for its cardiovascular diagnostic tools. Product reviews highlight the potential for improved accuracy and efficiency in cardiac assessments, while employer reviews often praise the company culture and mission. However, some employer feedback points to challenges common in rapidly growing tech companies.
Overall: PositiveStrengths
- Innovative AI technology for cardiovascular diagnostics (EchoGo platform)
- Potential for improved accuracy and efficiency in cardiac assessments
- Strong company culture and mission-driven environment (employer reviews)
- Supportive colleagues and management (employer reviews)
- Opportunity to work on impactful projects
- Good work-life balance reported by some employees
Limitations
- Rapid growth can lead to some organizational challenges
- Potential for high workload at times
- Specific product cons are not widely detailed in public reviews
- Compensation could be more competitive for some roles (employer reviews)
- Limited public product reviews from platforms like G2/Capterra
- Some employees desire more structured career development paths
Based on reviews from: Glassdoor, Reddit, Healthcare IT News articles/mentions, Ultromics.com (for product information context)
Last updated: 2026-07-17
Videos
News, demos, and interviews about Ultromics.
Videos load interactively. If none appear, search YouTube for Ultromics →
Press & Coverage
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]